By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Race Oncology Limited 

50 Kings Park Road
Level 2
West Perth  Western   6005  Australia
Phone: 1300-288-664 or 61-2-9698-5414 Fax: n/a


SEARCH JOBS

Race Oncology is a specialty pharmaceutical company, whose business model is to pursue later stage drug assets, principally in the cancer field. Our first important asset is a chemotherapy drug, called Bisantrene, which was the subject of more than 40 phase II clinical studies, before it was lost in a series of pharmaceutical mergers during the 1990s. Race Oncology is rediscovering Bisantrene. We own recent patent filings on Bisantrene and have secured Orphan Drug Designation in the US. Now our goal is to complete final development of Bisantrene and bring this valuable cancer drug to market.

YEAR FOUNDED:

2011

LEADERSHIP:

CEO: Peter Molloy

CSO: Dr. John Rothman

Senior VP, Business Development: Gordon Beck

Chairman: Dr. William Garner

Director: Dr. Brendan de Kauwe

Director: Chris Ntoumenopoulos


Key Statistics


Email: info@raceoncology.com
Ownership: Private

Web Site: Race Oncology
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
Currently No News Articles
//-->